Idera Pharmaceuticals, Inc.
Add To Watchlist
18.950 Million USD
Idera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for rare disease indications in the United States. It offers Tilsotolimod (IMO-2125), a synthetic phosphorothioate oligonucleotide that acts as a direct agonist of TLR9 to stimulate the immune systems and for treating solid tumors, squamous cell carcinoma of the head and neck, and colorectal cancer. The company has a collaboration agreement with Bristol-Meyers Squibb. Idera Pharmaceuticals, Inc. was incorporated in 1989 and is headquartered in Exton, Pennsylvania.
PennyStocks 13:00 21/05/2022
Buying Penny Stocks Right Now? 3 Top Tips to Know
What you need to know about trading penny stocks right now The p...
PennyStocks 16:11 18/05/2022
3 Penny Stocks That Are Climbing During Today's Market Selloff
Are these three penny stocks on your watchlist right now? The po...
Benzinga 12:05 17/05/2022
Why Are Idera Pharmaceuticals Shares Soaring Today
Idera Pharmaceuticals Inc (NASDAQ: IDRA) shared positive interim...
PennyStocks 13:45 19/04/2022
5 Top Biotech Penny Stocks Under $1 To Watch This Week
Top penny stocks to watch under $1 in April if you like Biotech ...